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T
he global epidemic of type 2 
diabetes is a pressing public 
health concern associated 
with a rapidly growing socioeconomic 
burden. Insulin resistance (IR) is an 
early event in the pathogenesis of type 
2 diabetes. IR is characterised by a 
reduced ability of insulin to stimulate 
glucose uptake in skeletal muscle 
and by hyperglycaemia (high blood 
glucose concentration), at ﬁ  rst only in 
periods following meal ingestion but 
later also in the overnight-fasted state. 
In patients with type 2 diabetes, 
IR is progressive and after several 
years often leads to the development 
of secondary diabetes symptoms 
(including hypertriglyceridaemia, 
obesity, and pathology of the macro- 
and microvasculature). Eventually 
(after more than ten years) severe 
medical complications may develop, 
including retinopathy, neuropathy, 
tissue necrosis in the extremities, renal 
failure, and cardiomyopathy. 
A progressive reduction over the last 
few decades of daily engagement in 
physically demanding activities and the 
recent growth in unbalanced diets are 
generally considered to be the primary 
causes of the dramatic rise in type 2 
diabetes [1]. A genetic predisposition 
also runs in families and populations. 
In this month’s PLoS Medicine, Kitt 
Petersen and colleagues [2] report new 
information on the early events in the 
underlying pathogenic mechanism that 
leads to the development of IR. 
The Study’s Findings
The authors investigated young, lean 
offspring with IR of parents with type 
2 diabetes [2]. The reason to select 
offspring with IR is that a metabolic 
defect observed in this group is likely to 
be an early event of genetic origin and, 
therefore, is potentially a primary cause 
of the subsequent development of type 
2 diabetes. 
The  offspring with IR were 
studied during a hyperinsulinaemic–
euglycaemic clamp. This test is 
traditionally used to diagnose IR. 
The test measures the ability of 
insulin to stimulate the clearance 
of glucose from the blood during a 
simultaneous infusion of insulin in 
supraphysiological quantities and 
of glucose in quantities sufﬁ  cient to 
maintain the glucose concentration at 
a normal physiological level. Petersen 
and colleagues found that infusion 
of insulin increased the turnover rate 
of adenosine triphosphate (ATP) 
in the skeletal muscle of control 
participants by 90%, while only a 5% 
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Figure 1. Potential Mechanisms Leading to Failure of Insulin to Stimulate Muscle ATP 
Turnover during a Hyperinsulinaemic–Euglycaemic Clamp in Offspring with IR 
The potential mechanisms are (1) a general mitochondrial dysfunction, reducing ATP production; 
(2) an impairment in the central nervous system (CNS) in the glucose- or insulin-induced excitation 
of muscle efferents, leading to reduced β-adrenergic activation of the muscle; (3) a reduced increase 
in mitochondrial ATP synthesis in response to activation of the β-adrenergic receptor (βAR); (4) a 
defect in insulin-induced opening of the terminal arterioles controlling blood ﬂ  ow through muscle 
ﬁ  bre capillaries and, thus, preventing increases in the insulin concentration in the interstitial ﬂ  uid 
and in binding of insulin to the insulin receptor (IR) in the muscle membrane; and (5) a molecular 
defect in the insulin signalling cascade in the muscle, leading to reduction in the insulin-induced 
stimulation of muscle glucose uptake, glycogen synthesis, and protein synthesis. ADP, adenosine 
diphosphate; NO, nitric oxide.PLoS Medicine  |  www.plosmedicine.org 0840
increase (nonsigniﬁ  cant) was seen in 
offspring with IR. The increase in ATP 
turnover in the control participants 
means that the metabolic rate (energy 
expenditure) of the muscle goes up 
during the clamp study. In an earlier 
study by the same group of researchers 
[3], offspring with IR also were 
observed to have 30% lower rates of 
muscle ATP turnover in the overnight-
fasted state. 
What Do These Findings Mean?
ATP in resting fasted muscles is 
only produced for purposes of cell 
maintenance and survival functions 
(for example, maintenance of sodium 
and potassium gradients, amino acid 
gradients, protein synthesis rates, and 
functional organelles and membranes). 
Hence, Petersen et al.’s observations 
suggest that either the basal energy 
requirement is reduced in muscles 
of individuals with IR (potentially at 
the expense of the maintenance of 
cell functions) or the major control 
systems for mitochondrial respiration 
(simultaneous ATP synthesis and 
consumption) are not properly working 
(Figure 1). 
Petersen and colleagues favour the 
ﬁ  rst explanation. They suggest that 
their combined observations point to a 
general mitochondrial dysfunction that 
impairs the ability of the mitochondria 
to synthesise ATP and oxidise fatty 
acids (FAs) at the normal resting rate, 
both in the basal overnight-fasted 
condition and after stimulation by 
insulin [2,3]. They also suggest that it 
is this mitochondrial dysfunction that 
causes IR. 
The mitochondrial dysfunction is 
hypothesised to lead to a reduced 
ability to oxidise FAs and to the 
accumulation of triglycerides and 
FA metabolites (fatty AcylCoA, 
diacylglycerols, and ceramides). Such 
accumulation of triglycerides and 
FA metabolites has been repeatedly 
observed, both in skeletal muscle of 
obese individuals [4,5] with a reduced 
insulin sensitivity and in the muscle 
of healthy individuals  given IR by 
the infusion of lipid emulsions and 
heparin [6]. These FA metabolites 
have been linked to the development 
of IR via a mechanism involving 
activation of protein kinase C and 
phosphorylation of the insulin receptor 
and IRS-1 at serine and threonine 
amino acid residues. Phosphorylation 
at these wrong amino acid residues 
prevents insulin-induced tyrosine 
phosphorylation of the insulin receptor 
and IRS-1, and prevents activation 
of the insulin signalling cascade; 
therefore, this mechanism is presently 
regarded as the primary cause of IR 
at the molecular level in the muscle 
[4–6]. 
But there is a problem with 
the assumption that a general 
mitochondrial dysfunction reduces 
both the basal and insulin-stimulated 
ATP production. In the muscle of 
both healthy control participants and 
patients with IR and type 2 diabetes, 
there is a large overcapacity in the ATP 
production capacity of skeletal muscle, 
allowing 5- to 20-fold increases in ATP 
turnover during exercise. Defects in 
resting mitochondrial ATP production, 
as occur in the muscle of patients with 
metabolic myopathies, lead to major 
reductions in the resting creatine 
phosphate/ATP ratio, and to a parallel 
increase in muscle lactate production 
as a consequence of a compensatory 
increase in the glycolytic ATP 
production. However, the offspring 
with IR in the previous studies by 
Petersen et al. [2,3] had normal resting 
creatine phosphate/ATP ratios and no 
change in muscle pH as a consequence 
of excessive lactate production. These 
ﬁ  ndings seem to argue against the 
hypothesis that there is a general 
mitochondrial defect in offspring with 
IR and patients with type 2 diabetes.
Alternative Explanations 
for the Findings
An important open question concerns 
the mechanism by which insulin 
would increase the resting muscle 
ATP turnover rate in the control 
participants. Total energy expenditure 
in human tissues can be roughly 
broken down in three components: 
(1) obligatory energy expenditure 
required to perform cell maintenance 
and survival functions and maintain cell 
and body temperatures at 37 °C, (2) 
adaptive energy expenditure induced 
by nutrient ingestion, and (3) energy 
expenditure required to perform 
muscle contractions and physical 
activity [7–9]. Total energy expenditure 
is the sum of the energy required 
to perform all cellular and organ 
functions, plus heat production. 
One possibility is that the increase 
in muscle ATP turnover, induced by 
insulin during the clamp, is caused by 
the well-known thermogenic effects 
of glucose and insulin [7–9]. Muscle 
glycogen synthesis and protein synthesis 
are energy-requiring metabolic 
processes, and both are stimulated 
when insulin binds to the insulin 
receptor in the muscle membrane. The 
stimulation of glycogen and protein 
synthesis leads to a need to increase 
muscle ATP turnover. As the efﬁ  ciency 
of mitochondrial respiration is only 
40%, increases in the rate of these 
metabolic reactions by deﬁ  nition 
contribute to heat production and the 
thermogenic effect of food ingestion. 
Therefore, insulin will increase 
muscle ATP production during the 
hyperinsulinaemic–euglycaemic clamp 
in healthy muscles in comparison to the 
basal state, while smaller increases in 
glycogen synthesis, in protein synthesis, 
and, therefore, in ATP production 
will occur in offspring with IR. This 
alternative mechanism explains the 
ﬁ  ndings observed in Petersen et al. [2], 
but does not implicate that there is a 
pre-existent mitochondrial dysfunction.
The autonomic nervous system is 
known to modulate the thermogenic 
effect of glucose by activating 
small efferent nerves that end in 
the interstitium of skeletal muscle 
(the ﬂ  uid that surrounds the 
muscle ﬁ  bres). The nerve endings 
produce noradrenalin, which 
activates β-adrenoreceptors in the 
muscle membrane, and this leads 
to an increase in mitochondrial 
ATP production. The part of 
glucose-induced thermogenesis 
that is eliminated by β-adrenergic 
antagonists has been called “facultative 
thermogenesis” and is assumed to 
take place at least in part in skeletal 
muscle [9]. It has also been suggested 
[9] that insulin, via unidentiﬁ  ed 
receptors, most probably located 
in the central nervous system, may 
stimulate muscle sympathetic nerve 
activity and facultative thermogenesis. 
Regular exercise and 
training should be 
considered interventions 
to correct the reduction 
in insulin-induced 
muscle ATP turnover.
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The thermogenic effect of insulin 
and carbohydrates has been shown 
to be reduced in obese and insulin-
resistant individuals [8,9]; therefore, an 
impairment in the mechanism leading 
to facultative thermogenesis may also 
explain a part of the reduction in 
insulin-stimulated muscle ATP synthesis 
observed in offspring with IR.
Recently, it has also been shown 
that insulin infusions lead to increases 
in blood ﬂ  ow through capillaries that 
surround the skeletal muscle ﬁ  bres, 
both in healthy humans and rats 
[10–12]. The mechanism involves 
the binding of insulin to the insulin 
receptor on the endothelial cell layer 
that covers the luminar wall of the 
terminal arterioles that control blood 
ﬂ  ow through the muscle capillaries 
(Figure 1). This binding leads to 
activation of the insulin signalling 
cascade in the endothelial cells and to 
nitric oxide production [11–13]. Nitric 
oxide, a muscle relaxant, then diffuses 
to the smooth-muscle cell layer and 
leads to relaxation of the sphincter 
muscle, dilation of the terminal 
arterioles, and recruitment of muscle 
capillaries (Figure 1). The opening 
of the muscle capillaries in healthy 
control rats precedes the insulin-
induced increase in glucose uptake, 
and the increase in glucose uptake 
can be prevented by prior infusion 
of nitric oxide synthase inhibitors. 
These observations suggest that 
insulin ﬁ  rst recruits muscle capillaries 
before it can reach the insulin 
receptor in the muscle membrane 
and stimulate muscle glucose uptake, 
glycogen and protein synthesis, and 
ATP production. Severe defects do 
exist in this insulin-induced opening 
mechanism in obese insulin-resistant 
Zucker rats [14]. Although failure of 
the insulin-induced recruitment of 
muscle capillaries has not yet been 
shown to exist in humans with IR, it 
could also explain the reduced insulin-
induced increase in muscle ATP 
synthesis rates in the offspring with IR 
observed by Petersen et al. [2], again 
without pointing to a mitochondrial 
defect or dysfunction. 
The Study’s Clinical Implications
Failure of insulin to stimulate muscle 
ATP production in offspring with IR 
may have multiple causes. A general 
mitochondrial dysfunction, as proposed 
by Petersen and colleagues, is one 
possibility, but the failure of insulin 
to (1) stimulate the insulin signalling 
cascade in muscle, (2) stimulate central 
thermogenic-control mechanisms of 
mitochondrial respiration, and (3) 
recruit muscle ﬁ  bre capillaries are 
other potential mechanisms. 
The basal observation that glucose 
and insulin do not stimulate muscle 
ATP production and thermogenesis in 
individuals with IR is clinically highly 
relevant, as it may explain the weight 
maintenance problems that people with 
IR experience. When there is a gradual 
reduction in the basal and insulin-
induced energy expenditure at the 
muscle level during the development 
of type 2 diabetes, food intake should 
be reduced in proportion to the lower 
ATP need of the muscles. Failure to 
correct for the lower muscle energy 
requirement will lead to a positive 
energy balance and to weight gain. 
The data in Petersen and colleagues’ 
study [2] also seem to suggest that the 
relative increase in energy expenditure 
by glucose and insulin is larger (90%) 
at the level of the muscle than at the 
level of the whole body (the whole-body 
thermogenic effect of orally ingested 
carbohydrates is maximally about 10%–
15% [8,9]). A gradual disappearance 
of this large energy component in 
individuals with IR will lead to a 
substantially lower calorie and nutrient 
requirement. 
Regular exercise and training should 
be considered interventions to correct 
the reduction in insulin-induced 
muscle ATP turnover. Endurance 
exercise performed three to four times 
per week may lead to more than 5-
fold increases in the mitochondrial 
density (concentration) of a previously 
sedentary muscle [15], and will 
increase the ATP generating capacity. 
Both endurance and resistance exercise 
increase insulin sensitivity at the 
molecular level in the muscle, and they 
have also been suggested to increase 
the sensitivity of adrenergic control 
in both skeletal muscle and adipose 
tissue [15]. Exercise and training 
open muscle capillaries and increase 
glucose uptake in skeletal muscle by 
contraction-induced mechanisms that 
are independent of insulin action 
[12,14]. The measurement of muscle 
ATP turnover with magnetic resonance 
spectroscopy, as used in Petersen et al. 
[2], seems to be an ideal noninvasive 
method to investigate one critically 
important question: can changes 
towards a more active lifestyle reverse 
the observed reduction in insulin-
induced muscle ATP turnover in the 
offspring with IR, and, in parallel, 
restore insulin sensitivity of muscle 
and precapillary arterioles and delay 
or prevent the later development of 
type 2 diabetes that was present in the 
parents?  
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